New legislation would suspend the Affordable Care Act’s medical device tax for 5 years; teenagers are now more likely to vape or use marijuana than smoke cigarettes; California women can access birth control at a pharmacist without a doctor’s prescription, but are unlikely to do so.
The medical device tax in the Affordable Care Act (ACA) has been a controversial provision that has already been delayed. Now, new legislation from Republicans in the House of Representatives could delay the implementation of the tax yet again, reported Forbes. The bill would suspend the 2.3% tax on medical devices sales for another 5 years. Republicans tried to pass a permanent repeal of the tax as part of their attempts to repeal and replace the ACA. Repealing the tax is expected to cost the US Treasury $20 billion over a decade.Cigarette smoking has dropped sharply among teenagers in the United States, and instead, vaping and marijuana use are more common. According to The New York Times, a survey found less than 10% of high school seniors reported smoking cigarettes in the last 30 days compared with 22.9% who used marijuana and 16.6% who had vaped. While the researchers were impressed with the reduction in cigarette smoking, they remain concerned that the health effects of vaping are still unknown. In addition, a very small percentage of respondents believed there was a “great risk” from smoking marijuana occasionally.Although California allows women to get birth control pills at a pharmacy without a prescription from their doctor, few women actually do. Only 11% of pharmacies in the state are dispensing birth control pills, which means women are having a hard time finding a place where they can get their contraceptives, according to Los Angeles Times. Some pharmacists are reluctant to offer birth control bills because of liability, lack of staffing, and reimbursement issues. In order to provide birth control to women, the pharmacist has to administer a questionnaire about health issues.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
Health Equity & Access Weekly Roundup: April 14, 2025
April 14th 2025From the potential impact of tariffs to the World Health Organization's year-long campaign launch focused on improving maternal and newborn health and addressing preventable deaths, here's the latest from the Center on Health Equity & Access.
Read More